CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Crum Brian T SVP, General Counsel & Secr. | Shares withheld for taxes | −25,604 | $2.62 | $67K | 177,497 |
| 2024-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise · Restricted Stock Units | −8,750 | 0 | ||
| 2024-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise · Restricted Stock Units | −26,096 | 26,097 | ||
| 2024-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise · Restricted Stock Units | −33,457 | 66,913 | ||
| 2024-02-28 | COATS LONNEL Chief Executive Officer | Option exercise | +33,333 | 947,692 | ||
| 2024-02-28 | COATS LONNEL Chief Executive Officer | Option exercise | +91,364 | 1,039,056 | ||
| 2024-02-28 | COATS LONNEL Chief Executive Officer | Option exercise | +120,383 | 1,159,439 | ||
| 2024-02-28 | COATS LONNEL Chief Executive Officer | Shares withheld for taxes | −61,371 | $2.62 | $161K | 1,098,068 |
| 2024-02-28 | COATS LONNEL Chief Executive Officer | Option exercise · Restricted Stock Units | −33,333 | 0 | ||
| 2024-02-28 | COATS LONNEL Chief Executive Officer | Option exercise · Restricted Stock Units | −91,364 | 91,363 | ||
| 2024-02-28 | COATS LONNEL Chief Executive Officer | Option exercise · Restricted Stock Units | −120,383 | 240,767 | ||
| 2024-02-08 | Alexander Kristen VP, Finance and Accounting | Grant or award · Restricted Stock Units | +59,660 | 59,660 | ||
| 2024-02-08 | Alexander Kristen VP, Finance and Accounting | Grant or award · Stock Option (Right to Buy) | +59,660 | 59,660 | ||
| 2024-02-08 | WADE JEFFREY L President and CFO | Grant or award · Restricted Stock Units | +314,320 | 314,320 | ||
| 2024-02-08 | WADE JEFFREY L President and CFO | Grant or award · Stock Option (Right to Buy) | +314,320 | 314,320 | ||
| 2024-02-08 | McDermott Wendy VP, Human Resources | Grant or award · Restricted Stock Units | +156,950 | 156,950 | ||
| 2024-02-08 | McDermott Wendy VP, Human Resources | Grant or award · Stock Option (Right to Buy) | +156,950 | 156,950 | ||
| 2024-02-08 | MAIN ALAN J EVP, Innov & Chem Sciences | Grant or award · Restricted Stock Units | +204,730 | 204,730 | ||
| 2024-02-08 | MAIN ALAN J EVP, Innov & Chem Sciences | Grant or award · Stock Option (Right to Buy) | +204,730 | 204,730 | ||
| 2024-02-08 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Grant or award · Restricted Stock Units | +203,810 | 203,810 |
Page 14 of 15 · 285 trades